Alcoholic cirrhosis and hepatocellular carcinoma

Adv Exp Med Biol. 2015:815:113-30. doi: 10.1007/978-3-319-09614-8_7.

Abstract

Hepatocellular carcinoma shows a rising incidence worldwide, and the largest burden of disease in Western countries derives from patients with alcoholic liver disease (ALD) and cirrhosis, the latter being the premier premalignant factor for HCC. The present chapter addresses key issues including the epidemiology of alcohol-associated HCC, and its link to other coexisting non-alcoholic liver diseases, and additional host and environmental risk factors including the underlying genetics. Also discussed are molecular mechanisms of alcohol-associated liver cancer evolution involving the mediators of alcohol toxicity and carcinogenicity, acetaldehyde and reactive oxygen species, as well as the recently described mutagenic adducts which these mediators form with DNA. Specifically, interference of alcohol with retinoids and cofactors of transmethylation processes are outlined. Information presented in this chapter illustrates that the development of HCC in the context of ALD is multifaceted and suggests several molecular targets for prevention and markers for the screening of risk groups.

Publication types

  • Review

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / etiology*
  • DNA Methylation
  • Humans
  • Liver Cirrhosis, Alcoholic / complications*
  • Liver Neoplasms / etiology*
  • Oxidative Stress